Literature DB >> 23533257

Sarcomatoid carcinoma represents a complete phenotype with various pathways of epithelial mesenchymal transition.

Chang Ohk Sung1, Hannah Choi, Keun-Woo Lee, Seok-Hyung Kim.   

Abstract

AIMS: Sarcomatoid carcinoma (SC) is considered to be a result of the sarcomatoid change of epithelial carcinoma. However, epithelial-mesenchymal transition (EMT) in SC has been insufficiently studied.
METHODS: We evaluated the expression patterns of EMT-related phenotypic markers with transcription factors in 27 SCs originating from various organs, and we investigated the phenotypic characteristics of SCs classified as complete, incomplete or wild-type. We further analysed correlations between EMT-related phenotype markers and transcription factors.
RESULTS: Epithelial markers (E-cadherin, claudin-3 and claudin-4) were consistently down-regulated, whereas mesenchymal markers (S100A4, α-smooth muscle actin (SMA), vimentin, PDGFRα and β-catenin) were variously expressed except for vimentin. EMT-related transcription factors (SIP1, Snail1, Slug, Twist1, ZEP1 and Oct-4) also showed various expression patterns. The expression patterns of phenotypic markers showed that most SCs (22/27, 81.5%, 95% CI 65.8 to 97.1%) had complete EMT phenotypes, whereas the remaining 5 (18.5%, 95% CI 2.8 to 24.1%) were of incomplete type. Unsupervised hierarchical clustering analysis revealed that SCs were clustered into several subgroups by EMT-related protein expression pattern. Twist1 positivity was significantly concordant with α-SMA positivity (κ value: 0.908; 95% CI 0.73 to 1.00, p<0.001, adjusted p<0.001). The EMT phenotypes of SC were simple, with complete phenotype being the predominant form, and the morphological changes of the SCs were also relevant in terms of EMT.
CONCLUSIONS: SC seems to be an irreversible, permanent change in the EMT phenomenon, with complete EMT phenotypes and various EMT-related pathways being involved in SC.

Entities:  

Keywords:  GASTROENTEROLOGY; HISTOPATHOLOGY; MOLECULAR ONCOLOGY; ONCOLOGY

Mesh:

Substances:

Year:  2013        PMID: 23533257     DOI: 10.1136/jclinpath-2012-201271

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.

Authors:  Jiaqi Mi; Erika Hooker; Steven Balog; Hong Zeng; Daniel T Johnson; Yongfeng He; Eun-Jeong Yu; Huiqing Wu; Vien Le; Dong-Hoon Lee; Joseph Aldahl; Mark L Gonzalgo; Zijie Sun
Journal:  J Biol Chem       Date:  2018-11-06       Impact factor: 5.157

2.  Sarcomatoid carcinomas of the gallbladder: clinicopathologic characteristics.

Authors:  Orhun Cig Taskin; Gizem Akkas; Bahar Memis; Ipek Erbarut Seven; Olca Basturk; Kee-Taek Jang; Juan C Roa; Juan Carlos Araya; Enrique Bellolio; Hector Losada; Juan Sarmiento; Serdar Balci; Burcin Pehlivanoglu; Michelle D Reid; Jill Koshiol; Volkan Adsay
Journal:  Virchows Arch       Date:  2019-06-08       Impact factor: 4.064

3.  Oral sarcomatoid squamous cell carcinoma: a retrospective study based on 14 cases.

Authors:  Jialiang Liu; Meng Xiao; Yan'an Wang
Journal:  Histol Histopathol       Date:  2019-10-23       Impact factor: 2.303

4.  Invasive urothelial carcinoma with chordoid features may be an ominous sign predicting sarcomatoid change: a case report of a bladder carcinoma.

Authors:  Shogo Tajima; Tomoyuki Suzuki; Yukio Yamada; Teppei Morikawa; Daisuke Minagawa; Yukio Homma; Masashi Fukayama
Journal:  Med Mol Morphol       Date:  2015-02-18       Impact factor: 2.309

Review 5.  Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Tian-Run Lv; Hai-Jie Hu; Parbatraj Regmi; Fei Liu; Fu-Yu Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-24       Impact factor: 4.553

6.  Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features.

Authors:  Timothy Ito; Jianming Pei; Essel Dulaimi; Craig Menges; Philip H Abbosh; Marc C Smaldone; David Y T Chen; Richard E Greenberg; Alexander Kutikov; Rosalia Viterbo; Robert G Uzzo; Joseph R Testa
Journal:  J Urol       Date:  2015-11-18       Impact factor: 7.450

7.  Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development.

Authors:  Chia-Hung Yen; Chih-Chung Lai; Chen-Chung Liao; Sheng-Fan Wang; Yi-Jen Liao; Chien-Yi Tung; Jung-Hsien Hung; Shiu-Feng Huang; Yi-Ming Arthur Chen
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

8.  Stochastic phenotype switching leads to intratumor heterogeneity in human liver cancer.

Authors:  Andrija Matak; Pooja Lahiri; Ethan Ford; Daniela Pabst; Karl Kashofer; Dimitris Stellas; Dimitris Thanos; Kurt Zatloukal
Journal:  Hepatology       Date:  2018-02-01       Impact factor: 17.298

9.  Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report.

Authors:  Hye Min Kim; Haeryoung Kim; Young Nyun Park
Journal:  Clin Mol Hepatol       Date:  2015-09-30

10.  Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature.

Authors:  Tomoko Yoshimoto; Shinichiro Kobayashi; Kengo Kanetaka; Kazuma Kobayashi; Yasuhiro Nagata; Michi Morita; Yuriko Isagawa; Naoe Kinoshita; Mitsuhisa Takatsuki; Susumu Eguchi
Journal:  Surg Case Rep       Date:  2018-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.